Advertisement
| drug discovery and development technology in transition: Drug Discovery and Development Raymond G. Hill, Duncan Richards, 2021-06 Essential insight into drug development and the pharmaceutical industry With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the new edition of Drug Discovery and Development is an essential resource for anyone interested in understanding how drugs and other therapeutic interventions are discovered and developed, through to clinical research, registration, and market access. The text has been thoroughly updated, with new information on biopharmaceuticals and vaccines as well as clinical development and target identification. Drug discovery and development continues to evolve rapidly and this new edition reflects important changes in the landscape. Edited by industry experts Raymond Hill and Duncan Richards, this market-leading text is suitable for undergraduates and graduates undertaking degrees in pharmacy, pharmacology, toxicology, and clinical development through to those embarking on a career in the pharmaceutical industry. Key stages of drug discovery and development Chapters outline the contribution of individual disciplines to the overall process Supplemented by specific chapters on different modalities Includes coverage of Oligonucleotide therapies; cell and gene therapy Now comes with online access on StudentConsult |
| drug discovery and development technology in transition: Drug Discovery and Development E-Book Raymond G Hill, Duncan Richards, 2021-05-16 With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the new edition of Drug Discovery and Development is an essential resource for anyone interested in understanding how drugs and other therapeutic interventions are discovered and developed, through to clinical research, registration, and market access. The text has been thoroughly updated, with new information on biopharmaceuticals and vaccines as well as clinical development and target identification. Drug discovery and development continues to evolve rapidly and this new edition reflects important changes in the landscape. Edited by industry experts Raymond Hill and Duncan Richards, this market-leading text is suitable for undergraduates and graduates undertaking degrees in pharmacy, pharmacology, toxicology, and clinical development through to those embarking on a career in the pharmaceutical industry. - Key stages of drug discovery and development - Chapters outline the contribution of individual disciplines to the overall process - Supplemented by specific chapters on different modalities - Includes coverage of Oligonucleotide therapies; cell and gene therapy - Now comes with online access on StudentConsult |
| drug discovery and development technology in transition: Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang, 2009-06-01 |
| drug discovery and development technology in transition: Drug Discovery and Development - E-Book Raymond G Hill, 2012-07-20 The modern pharmacopeia has enormous power to alleviate disease, and owes its existence almost entirely to the work of the pharmaceutical industry. This book provides an introduction to the way the industry goes about the discovery and development of new drugs. The first part gives a brief historical account from its origins in the mediaeval apothecaries' trade, and discusses the changing understanding of what we mean by disease, and what therapy aims to achieve, as well as summarising case histories of the discovery and development of some important drugs. The second part focuses on the science and technology involved in the discovery process: the stages by which a promising new chemical entity is identified, from the starting point of a medical need and an idea for addressing it. A chapter on biopharmaceuticals, whose discovery and development tend to follow routes somewhat different from synthetic compounds, is included here, as well as accounts of patent issues that arise in the discovery phase, and a chapter on research management in this environment. The third section of the book deals with drug development: the work that has to be undertaken to turn the drug candidate that emerges from the discovery process into a product on the market. - The definitive introduction to how a pharmaceutical company goes about its business of discovering and developing drugs. The second edition has a new editor: Professor Raymond Hill ● non-executive director of Addex Pharmaceuticals, Covagen and of Orexo AB ● Visiting Industrial Professor of Pharmacology in the University of Bristol ● Visiting Professor in the School of Medical and Health Sciences at the University of Surrey ● Visiting Professor in Physiology and Pharmacology at the University of Strathclyde ● President and Chair of the Council of the British Pharmacological Society ● member of the Nuffield Council on Bioethics and the Advisory Council on Misuse of Drugs. New to this edition: - Completely rewritten chapter on The Role of Medicinal Chemistry in the Drug Discovery Process. - New topic - DMPK Optimization Strategy in drug discovery. - New chapter on Scaffolds: Small globular proteins as antibody substitutes. - Totally updated chapters on Intellectual Property and Marketing - 50 new illustrations in full colour Features - Accessible, general guide to pharmaceutical research and development. - Examines the interfaces between cost and social benefit, quality control and mass production, regulatory bodies, patent management, and all interdisciplinary intersections essential to effective drug development. - Written by a strong team of scientists with long experience in the pharmaceutical industry. - Solid overview of all the steps from lab bench to market in an easy-to-understand way which will be accessible to non-specialists. From customer reviews of the previous edition: '... it will have everything you need to know on this module. Deeply referenced and, thus, deeply reliable. - Highly Commended in the medicine category of the BMA 2006 medical book competition - Winner of the Royal Society of Medicine Library Prize for Medical Book of the Year |
| drug discovery and development technology in transition: Drug Discovery and Development H. P. Rang, 2006 This title is directed primarily toward health care professionals outside the United States. An ideal introduction to the pharmaceutical industry, this book describes the process of bringing a new drug to the marketplace. It explains why, although thousands of compounds show initial promise, only a small handful will be developed for human clinical trials and perhaps only one will become an approved drug. Describing the huge complexities involved, it shows how new molecular understanding and techniques can make the process more targeted and successful. |
| drug discovery and development technology in transition: Basic Principles of Drug Discovery and Development Benjamin E. Blass, 2021-03-30 Basic Principles of Drug Discovery and Development presents the multifaceted process of identifying a new drug in the modern era, which requires a multidisciplinary team approach with input from medicinal chemists, biologists, pharmacologists, drug metabolism experts, toxicologists, clinicians, and a host of experts from numerous additional fields. Enabling technologies such as high throughput screening, structure-based drug design, molecular modeling, pharmaceutical profiling, and translational medicine are critical to the successful development of marketable therapeutics. Given the wide range of disciplines and techniques that are required for cutting edge drug discovery and development, a scientist must master their own fields as well as have a fundamental understanding of their collaborator's fields. This book bridges the knowledge gaps that invariably lead to communication issues in a new scientist's early career, providing a fundamental understanding of the various techniques and disciplines required for the multifaceted endeavor of drug research and development. It provides students, new industrial scientists, and academics with a basic understanding of the drug discovery and development process. The fully updated text provides an excellent overview of the process and includes chapters on important drug targets by class, in vitro screening methods, medicinal chemistry strategies in drug design, principles of in vivo pharmacokinetics and pharmacodynamics, animal models of disease states, clinical trial basics, and selected business aspects of the drug discovery process. - Provides a clear explanation of how the pharmaceutical industry works, as well as the complete drug discovery and development process, from obtaining a lead, to testing the bioactivity, to producing the drug, and protecting the intellectual property - Includes a new chapter on the discovery and development of biologics (antibodies proteins, antibody/receptor complexes, antibody drug conjugates), a growing and important area of the pharmaceutical industry landscape - Features a new section on formulations, including a discussion of IV formulations suitable for human clinical trials, as well as the application of nanotechnology and the use of transdermal patch technology for drug delivery - Updated chapter with new case studies includes additional modern examples of drug discovery through high through-put screening, fragment-based drug design, and computational chemistry |
| drug discovery and development technology in transition: Drugs Rick Ng, 2011-09-20 Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. —Doody's Reviews, May 2009 The second edition of a book that offers a user-friendly step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical trials. —Chemistry World, February 2009 The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. This second edition features many key enhancements, including Key Points, Chapter Summary, and Review Questions in each chapter, Answers to Review Questions provided in a book-end appendix, and one or two carefully selected mini case studies in each chapter. Richly illustrated throughout with over ninety figures and tables, this important book also includes helpful listings of current FDA and European guidelines and a special section on regulatory authority and processes in China. It is an indispensable resource for pharmaceutical industry and academic researchers, pharmaceutical managers and executives, healthcare clinicians, policymakers, regulators, and lobbyists with an interest in drug development. It is also an excellent textbook for students in pharmacy, science, and medicine courses. |
| drug discovery and development technology in transition: Drug Discovery and Evaluation: Pharmacological Assays Hans Vogel, 2007-10-30 The new edition of this successful reference offers both cutting-edge and classic pharmacological methods. Thoroughly revised and expanded to two volumes, it offers an updated selection of the most frequently used assays for reliably detecting the pharmacological effects of potential drugs. Every chapter has been updated, and numerous assays have been added. Each of the more than 1,000 assays comprises a detailed protocol outlining purpose and rationale, and a critical assessment of the results and their pharmacological and clinical relevance. |
| drug discovery and development technology in transition: Innovative Approaches in Drug Discovery Bhushan Patwardhan, Rathnam Chaguturu, 2016-10-03 Despite considerable technological advances, the pharmaceutical industry is experiencing a severe innovation deficit, especially in the discovery of new drugs. Innovative Approaches in Drug Discovery: Ethnopharmacology, Systems Biology and Holistic Targeting provides a critical review and analysis of health, disease and medicine, and explores possible reasons behind the present crisis in drug discovery. The authors illustrate the benefits of systems biology and pharmacogenomics approaches, and advocate the expansion from disease-centric discovery to person-centric therapeutics involving holistic, multi-target, whole systems approaches. This book lays a path for reigniting pharmaceutical innovation through a disciplined reemergence of pharmacognosy, embracing open innovation models and collaborative, trusted public-private partnerships. With unprecedented advances made in the development of biomedically-relevant tools and technologies, the need is great and the time is now for a renewed commitment towards expanding the repertoire of medicines. By incorporating real-life examples and state-of-the-art reviews, this book provides valuable insights into the discovery and development strategies for professionals, academicians, and students in the pharmaceutical sciences. - Analyzes the reasons behind historical drug failures to provide valuable insights on lessons learned - Uses current scientific research to promote learning from traditional knowledge systems and through the integration of traditional and western medicines - Discusses advances in technologies and systems biology to support the transition from formulation discovery to therapeutic discovery |
| drug discovery and development technology in transition: Bioinformatics and Computational Biology in Drug Discovery and Development William T. Loging, 2016-03-17 A comprehensive overview of the use of computational biology approaches in the drug discovery and development process. |
| drug discovery and development technology in transition: The Drug Discovery and Development Cycle Kabir Hussain, 2020-07-19 The pharmaceutical drug discovery and development cycle is long and complex. This book provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development. |
| drug discovery and development technology in transition: Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays H. Gerhard Vogel, Franz J. Hock, Jochen Maas, Dieter Mayer, 2006-09-21 This book is a landmark in the continuously changing world of drugs. As such it is important reading for many groups: not only for all students of pharmacology and toxicology but also for physicians, especially those involved in clinical trials of drugs, and for pharmacists who have to know the safety requirements of drugs. The book is absolutely essential for scientists and managers in the pharmaceutical industry who are involved in drug finding, drug development and decision making in the development process. In particular, the book will be of use for government institutions and committees working on official guidelines for drug evaluation worldwide. |
| drug discovery and development technology in transition: Accounts in Drug Discovery Joel Barrish, Percy Carter, Peter Cheng, Robert Zahler, 2011 Accounts in Drug Discovery describes recent case studies in medicinal chemistry with a particular emphasis on how the inevitable problems that arise during any project can be surmounted or overcome. The Editors cover a wide range of therapeutic areas and medicinal chemistry strategies, including lead optimization starting from high-throughput screening hits as well as rational, structure-based design. The chapters include follow-ons and next generation compounds that aim to improve upon first-generation agents. This volume surveys the range of challenges commonly faced by medicinal chemistry researchers, including the optimization of metabolism and pharmacokinetics, toxicology, pharmaceutics and pharmacology, including proof-of-concept in the clinic for novel biological targets. The case studies include medicinal chemistry stories on recently approved and marketed drugs, but also chronicle near-misses, i.e. exemplary compounds that may have proceeded well into the clinic but for various reasons did not result in a successful registration. As the vast majority of projects fail prior to registration, much can be learned from such narratives. By sharing a wide range of drug discovery experiences and information across the community of medicinal chemists in both industry and academia, the Editors believe that these accounts will provide insights into the art of medicinal chemistry as it is currently practiced and will help to serve the needs of active medicinal chemists. |
| drug discovery and development technology in transition: Improving and Accelerating Therapeutic Development for Nervous System Disorders Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, 2014-02-06 Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline. There are several challenges to the current drug development pipeline for nervous system disorders. The fundamental etiology and pathophysiology of many nervous system disorders are unknown and the brain is inaccessible to study, making it difficult to develop accurate models. Patient heterogeneity is high, disease pathology can occur years to decades before becoming clinically apparent, and diagnostic and treatment biomarkers are lacking. In addition, the lack of validated targets, limitations related to the predictive validity of animal models - the extent to which the model predicts clinical efficacy - and regulatory barriers can also impede translation and drug development for nervous system disorders. Improving and Accelerating Therapeutic Development for Nervous System Disorders identifies avenues for moving directly from cellular models to human trials, minimizing the need for animal models to test efficacy, and discusses the potential benefits and risks of such an approach. This report is a timely discussion of opportunities to improve early drug development with a focus toward preclinical trials. |
| drug discovery and development technology in transition: Structure-based Design of Drugs and Other Bioactive Molecules Arun K. Ghosh, Sandra Gemma, 2014-08-11 Drug design is a complex, challenging and innovative research area. Structure-based molecular design has transformed the drug discovery approach in modern medicine. Traditionally, focus has been placed on computational, structural or synthetic methods only in isolation. This one-of-akind guide integrates all three skill sets for a complete picture of contemporary structure-based design. This practical approach provides the tools to develop a high-affinity ligand with drug-like properties for a given drug target for which a high-resolution structure exists. The authors use numerous examples of recently developed drugs to present best practice methods in structurebased drug design with both newcomers and practicing researchers in mind. By way of a carefully balanced mix of theoretical background and case studies from medicinal chemistry applications, readers will quickly and efficiently master the basic skills of successful drug design. This book is aimed at new and active medicinal chemists, biochemists, pharmacologists, natural product chemists and those working in drug discovery in the pharmaceutical industry. It is highly recommended as a desk reference to guide students in medicinal and chemical sciences as well as to aid researchers engaged in drug design today. |
| drug discovery and development technology in transition: Biomolecular Simulations in Structure-Based Drug Discovery Francesco L. Gervasio, Vojtech Spiwok, Raimund Mannhold, 2019-04-29 A guide to applying the power of modern simulation tools to better drug design Biomolecular Simulations in Structure-based Drug Discovery offers an up-to-date and comprehensive review of modern simulation tools and their applications in real-life drug discovery, for better and quicker results in structure-based drug design. The authors describe common tools used in the biomolecular simulation of drugs and their targets and offer an analysis of the accuracy of the predictions. They also show how to integrate modeling with other experimental data. Filled with numerous case studies from different therapeutic fields, the book helps professionals to quickly adopt these new methods for their current projects. Experts from the pharmaceutical industry and academic institutions present real-life examples for important target classes such as GPCRs, ion channels and amyloids as well as for common challenges in structure-based drug discovery. Biomolecular Simulations in Structure-based Drug Discovery is an important resource that: -Contains a review of the current generation of biomolecular simulation tools that have the robustness and speed that allows them to be used as routine tools by non-specialists -Includes information on the novel methods and strategies for the modeling of drug-target interactions within the framework of real-life drug discovery and development -Offers numerous illustrative case studies from a wide-range of therapeutic fields -Presents an application-oriented reference that is ideal for those working in the various fields Written for medicinal chemists, professionals in the pharmaceutical industry, and pharmaceutical chemists, Biomolecular Simulations in Structure-based Drug Discovery is a comprehensive resource to modern simulation tools that complement and have the potential to complement or replace laboratory assays for better results in drug design. |
| drug discovery and development technology in transition: Natural Product Chemistry for Drug Discovery Antony D Buss, Mark S Butler, 2009-10-21 Natural Product Chemistry for Drug Discovery provides a comprehensive summary of where natural product chemistry is today in drug discovery. The book covers emerging technologies and case studies and is a source of up-to-date information on the topical subject of natural products. Natural products are once again considered important tools in the drug discovery toolbox. The authors are all experts in their respective fields of natural product chemistry. The book will appeal across the board from scientists to professionals, postgraduates and industrial chemists. The case studies selected for inclusion highlight recently marketed drugs and development candidates that have been derived from natural products. These 'real-life' examples show how new technologies, such as advances in screening, isolation, dereplication and prefractionation, have significantly enhanced the discovery process. |
| drug discovery and development technology in transition: Colloid and Interface Science in Pharmaceutical Research and Development Hiroyuki Ohshima, Kimiko Makino, 2014-07-23 Colloid and Interface Science in Pharmaceutical Research and Development describes the role of colloid and surface chemistry in the pharmaceutical sciences. It gives a detailed account of colloid theory, and explains physicochemical properties of the colloidal-pharmaceutical systems, and the methods for their measurement. The book starts with fundamentals in Part I, covering fundamental aspects of colloid and interface sciences as applied to pharmaceutical sciences and thus should be suitable for teaching. Parts II and III treat applications and measurements, and they explains the application of these properties and their influence and use for the development of new drugs. - Provides a clear description of the fundamentals of colloid and interface science relevant to drug research and development - Explains the physicochemical/colloidal basis of pharmaceutical science - Lists modern experimental characterization techniques, provides analytical equations and explanations on analyzing the experimental data - Describes the most advanced techniques, AFM (Atomic Force Microscopy), SFA (Surface Force Apparatus) in detail |
| drug discovery and development technology in transition: Biomarkers in Drug Development Michael R. Bleavins, Claudio Carini, Mallé Jurima-Romet, Ramin Rahbari, 2011-09-20 Discover how biomarkers can boost the success rate of drug development efforts As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of the drug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine. Biomarkers in Drug Development is divided into eight parts: Part One offers an overview of biomarkers and their role in drug development. Part Two highlights important technologies to help researchers identify new biomarkers. Part Three examines the characterization and validation process for both drugs and diagnostics, and provides practical advice on appropriate statistical methods to ensure that biomarkers fulfill their intended purpose. Parts Four through Six examine the application of biomarkers in discovery, preclinical safety assessment, clinical trials, and translational medicine. Part Seven focuses on lessons learned and the practical aspects of implementing biomarkers in drug development programs. Part Eight explores future trends and issues, including data integration, personalized medicine, and ethical concerns. Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development. |
| drug discovery and development technology in transition: Applications of Transition Metal Catalysis in Drug Discovery and Development Matthew L. Crawley, Barry M. Trost, 2012-05-14 This book focuses on the drug discovery and development applications of transition metal catalyzed processes, which can efficiently create preclinical and clinical drug candidates as well as marketed drugs. The authors pay particular attention to the challenges of transitioning academically-developed reactions into scalable industrial processes. Additionally, the book lays the groundwork for how continued development of transition metal catalyzed processes can deliver new drug candidates. This work provides a unique perspective on the applications of transition metal catalysis in drug discovery and development – it is a guide, a historical prospective, a practical compendium, and a source of future direction for the field. |
| drug discovery and development technology in transition: Pharmaceutical Substances Axel Kleemann, Jürgen Engel, 2001 The 4th edition of Pharmaceutical Substances is designed to be a complete reference guide to every pharmaceutical compounds of significance. It provides a compendium of nearly 2300 pharmaceutical ingredients of interest to the chemical and pharmaceutical industries. Pharmaceutical Substances is an invaluable resource for anybody involved in the design, discovery, development, and evaluation of drugs. It is available in print and online, for more information on these formats visit: www.thieme-chemistry.com Together with their co-authors, Bernhard Kutscher and Dietmar Reichert they have created an indispensable tool for researchers. Pharmaceutical Substances is a first point of reference for any person wishing to screen references to drugs before turning to more detailed primary literature, such as the original patent application or the original research paper. Extensive indexing and cross linking of references provides the reader with a fast and easy way to compare pharmaceutical ingredients with similar characteristics. |
| drug discovery and development technology in transition: Drug Discovery and Development Ramarao Poduri, 2021-02-15 This book describes the processes that are involved in the development of new drugs. The authors discuss the history, role of natural products and concept of receptor interactions with regard to the initial stages of drug discovery. In a single, highly readable volume, it outlines the basics of pharmacological screening, drug target identification, and genetics involved in early drug discovery. The final chapters introduce readers to stem therapeutics, pharmacokinetics, pharmacovigilance, and toxicological testing. Given its scope, the book will enable research scholars, professionals and young scientists to understand the key fundamentals of drug discovery, including stereochemistry, pharmacokinetics, clinical trials, statistics and toxicology. |
| drug discovery and development technology in transition: Modern Methods of Clinical Investigation Institute of Medicine, Committee on Technological Innovation in Medicine, 1990-02-01 The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians. |
| drug discovery and development technology in transition: Carbohydrates in Drug Discovery and Development Vinod K. Tiwari, 2020-08-01 Carbohydrates in Drug Discovery and Development: Synthesis and Applications examines recent and notable developments in the synthesis, biology, therapeutic, and biomedical applications of carbohydrates, which is considered to be a highly promising area of research in the field of medicinal chemistry. Their role in several important biological processes, notably energy storage, transport, modulation of protein function, intercellular adhesion, malignant transformation, signal transduction, viral, and bacterial cell surface recognition formulate the carbohydrate systems to be an exceedingly considerable scaffold for the development of new chemical entities of pharmacological importance. In addition to their easy accessibility, high functionality and chiralpool characteristics are the few additional fascinating structural features of carbohydrates, which further enhance their utilities and thus they have been able to attract chemists and biologists toward harnessing these properties for the past several decades.This book covers an advanced aspect of carbohydrate-based molecular scaffolding, starting with a general introduction followed by a detailed discussion about the impact of diverse carbohydrate-containing molecules of great therapeutic values and their impact on drug discovery and development. The topics covered in this book include the significance of heparin mimetics as the possible tools for the modulation of biology and therapy, chemistry and bioactivities of C-glycosylated compounds, inositols, iminosugars, KDO, sialic acids, glycohybrids, macrocycles, plant oligosaccharides, anti-bacterial and anti-cancer vaccines, antibiotics, and more. |
| drug discovery and development technology in transition: Career Opportunities in Biotechnology and Drug Development Toby Freedman, 2008 An essential guide for students in the life sciences, established researchers, and career counselors, this resource features discussions of job security, future trends, and potential career paths. Even those already working in the industry will find helpful information on how to take advantage of opportunities within their own companies and elsewhere. |
| drug discovery and development technology in transition: Systems Biology in Drug Discovery and Development Daniel L. Young, Seth Michelson, 2011-09-23 The first book to focus on comprehensive systems biology as applied to drug discovery and development Drawing on real-life examples, Systems Biology in Drug Discovery and Development presents practical applications of systems biology to the multiple phases of drug discovery and development. This book explains how the integration of knowledge from multiple sources, and the models that best represent that integration, inform the drug research processes that are most relevant to the pharmaceutical and biotechnology industries. The first book to focus on comprehensive systems biology and its applications in drug discovery and development, it offers comprehensive and multidisciplinary coverage of all phases of discovery and design, including target identification and validation, lead identification and optimization, and clinical trial design and execution, as well as the complementary systems approaches that make these processes more efficient. It also provides models for applying systems biology to pharmacokinetics, pharmacodynamics, and candidate biomarker identification. Introducing and explaining key methods and technical approaches to the use of comprehensive systems biology on drug development, the book addresses the challenges currently facing the pharmaceutical industry. As a result, it is essential reading for pharmaceutical and biotech scientists, pharmacologists, computational modelers, bioinformaticians, and graduate students in systems biology, pharmaceutical science, and other related fields. |
| drug discovery and development technology in transition: Innovation and Marketing in the Pharmaceutical Industry Min Ding, Jehoshua Eliashberg, Stefan Stremersch, 2013-10-31 The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike. |
| drug discovery and development technology in transition: Artificial Intelligence in Drug Discovery Nathan Brown, 2020-11-04 Following significant advances in deep learning and related areas interest in artificial intelligence (AI) has rapidly grown. In particular, the application of AI in drug discovery provides an opportunity to tackle challenges that previously have been difficult to solve, such as predicting properties, designing molecules and optimising synthetic routes. Artificial Intelligence in Drug Discovery aims to introduce the reader to AI and machine learning tools and techniques, and to outline specific challenges including designing new molecular structures, synthesis planning and simulation. Providing a wealth of information from leading experts in the field this book is ideal for students, postgraduates and established researchers in both industry and academia. |
| drug discovery and development technology in transition: A Practical Guide to Drug Development in Academia Daria Mochly-Rosen, Kevin Grimes, 2014-07-08 A lot of hard-won knowledge is laid out here in a brief but informative way. Every topic is well referenced, with citations from both the primary literature and relevant resources from the internet. Review from Nature Chemical Biology Written by the founders of the SPARK program at Stanford University, this book is a practical guide designed for professors, students and clinicians at academic research institutions who are interested in learning more about the drug development process and how to help their discoveries become the novel drugs of the future. Often many potentially transformative basic science discoveries are not pursued because they are deemed ‘too early’ to attract industry interest. There are simple, relatively cost-effective things that academic researchers can do to advance their findings to the point that they can be tested in the clinic or attract more industry interest. Each chapter broadly discusses an important topic in drug development, from preclinical work in assay design through clinical trial design, regulatory issues and marketing assessments. After the practical overview provided here, the reader is encouraged to consult more detailed texts on specific topics of interest. I would actually welcome it if this book’s intended audience were broadened even more. Younger scientists starting out in the drug industry would benefit from reading it and getting some early exposure to parts of the process that they’ll eventually have to understand. Journalists covering the industry (especially the small startup companies) will find this book a good reality check for many an over-hopeful press release. Even advanced investors who might want to know what really happens in the labs will find information here that might otherwise be difficult to track down in such a concentrated form. |
| drug discovery and development technology in transition: Remington Adeboye Adejare, 2020-11-03 The PCP's Bicentennial Edition Remington: The Science and Practice of Pharmacy, Twenty Third Edition, offers a trusted, completely updated source of information for education, training, and development of pharmacists. Published for the first time with Elsevier, this edition includes coverage of biologics and biosimilars as uses of those therapeutics have increased substantially since the previous edition. Also discussed are formulations, drug delivery (including prodrugs, salts, polymorphism. With clear, detailed color illustrations, fundamental information on a range of pharmaceutical science areas, and information on new developments in industry, pharmaceutical industry scientists, especially those involved in drug discovery and development will find this edition of Remington an essential reference. Intellectual property professionals will also find this reference helpful to cite in patents and resulting litigations. Additional graduate and postgraduate students in Pharmacy and Pharmaceutical Sciences will refer to this book in courses dealing with medicinal chemistry and pharmaceutics. - Contains a comprehensive source of principles of drug discovery and development topics, especially for scientists that are new in the pharmaceutical industry such as those with trainings/degrees in chemistry and engineering - Provides a detailed source for formulation scientists and compounding pharmacists, from produg to excipient issues - Updates this excellent source with the latest information to verify facts and refresh on basics for professionals in the broadly defined pharmaceutical industry |
| drug discovery and development technology in transition: Complete Accounts of Integrated Drug Discovery and Development Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa Vaidyanathan, 2020-10-09 These engaging accounts walk readers through the drug discovery and development processes, from identification of a target compound to the development of large-scale processes. The authors hail from leading pharmaceutical companies, grounding the text in real-world applications. These accounts also touch on reaction safety and development costs, providing insight into often closed-door procedures. These relevant examples from industry are informative to chemists in both industry and academia, especially those interested in discovering and developing drug candidates. |
| drug discovery and development technology in transition: The Road from Nanomedicine to Precision Medicine Shaker A. Mousa, Raj Bawa, Gerald F. Audette, 2020-01-17 The enormous advances in nanomedicine and precision medicine in the past two decades necessitated this comprehensive reference, which can be relied upon by researchers, clinicians, pharmaceutical scientists, regulators, policymakers, and lawyers alike. This standalone, full-color resource broadly surveys innovative technologies and advances pertaining to nanomedicine and precision medicine. In addition, it addresses often-neglected yet crucial areas such as translational medicine, intellectual property law, ethics, policy, FDA regulatory issues, nano-nomenclature, and artificial nano-machines—all accomplished in a user-friendly, broad yet interconnected format. The book is essential reading for the novice and the expert alike in diverse fields such as medicine, law, pharmacy, genomics, biomedical sciences, ethics, and regulatory science. The book’s multidisciplinary approach will attract a global audience and serve as a valuable reference resource for industry, academia, and government. |
| drug discovery and development technology in transition: The Organic Chemistry of Drug Design and Drug Action Richard B. Silverman, 2012-12-02 Standard medicinal chemistry courses and texts are organized by classes of drugs with an emphasis on descriptions of their biological and pharmacological effects. This book represents a new approach based on physical organic chemical principles and reaction mechanisms that allow the reader to extrapolate to many related classes of drug molecules. The Second Edition reflects the significant changes in the drug industry over the past decade, and includes chapter problems and other elements that make the book more useful for course instruction. - New edition includes new chapter problems and exercises to help students learn, plus extensive references and illustrations - Clearly presents an organic chemist's perspective of how drugs are designed and function, incorporating the extensive changes in the drug industry over the past ten years - Well-respected author has published over 200 articles, earned 21 patents, and invented a drug that is under consideration for commercialization |
| drug discovery and development technology in transition: Pharmaceutical Medicine and Translational Clinical Research Divya Vohora, Gursharan Singh, 2017-11-14 Pharmaceutical Medicine and Translational Clinical Research covers clinical testing of medicines and the translation of pharmaceutical drug research into new medicines, also focusing on the need to understand the safety profile of medicine and the benefit-risk balance. Pharmacoeconomics and the social impact of healthcare on patients and public health are also featured. It is written in a clear and straightforward manner to enable rapid review and assimilation of complex information and contains reader-friendly features.As a greater understanding of these aspects is critical for students in the areas of pharmaceutical medicine, clinical research, pharmacology and pharmacy, as well as professionals working in the pharmaceutical industry, this book is an ideal resource. - Includes detailed coverage of current trends and key topics in pharmaceutical medicine, including biosimilars, biobetters, super generics, and - Provides a comprehensive look at current and important aspects of the science and regulation of drug and biologics discovery |
| drug discovery and development technology in transition: ADKAR Jeff Hiatt, 2006 In his first complete text on the ADKAR model, Jeff Hiatt explains the origin of the model and explores what drives each building block of ADKAR. Learn how to build awareness, create desire, develop knowledge, foster ability and reinforce changes in your organization. The ADKAR Model is changing how we think about managing the people side of change, and provides a powerful foundation to help you succeed at change. |
| drug discovery and development technology in transition: The Changing Economics of Medical Technology Institute of Medicine, Committee on Technological Innovation in Medicine, 1991-02-01 Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€as well as the involvement of numerous government agenciesâ€affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public. |
| drug discovery and development technology in transition: Bioinformatics and Drug Discovery Richard S. Larson, 2012 Recent advances in drug discovery have been rapid. The second edition of Bioinformatics and Drug Discovery has been completely updated to include topics that range from new technologies in target identification, genomic analysis, cheminformatics, protein analysis, and network or pathway analysis. Each chapter provides an extended introduction that describes the theory and application of the technology. In the second part of each chapter, detailed procedures related to the use of these technologies and software have been incorporated. Written in the highly successful Methods in Molecular Biology series format, the chapters include the kind of detailed description and implementation advice that is crucial for getting optimal results in the laboratory. Thorough and intuitive, Bioinformatics and Drug Discovery, Second Edition seeks to aid scientists in the further study of the rapidly expanding field of drug discovery. |
| drug discovery and development technology in transition: Drug Design: Principles and Applications Abhinav Grover, 2018-12-12 This book offers an in-depth discussion of the latest strategies in the field of drug design and their applications in various disorders, in order to encourage readers to undertake their own projects.It also includes the contemporary application of drug-designing methodologies to inspire others to further expand the utility of this field in other diseases.It is intended for advanced undergraduate and graduate students, postdocs, researchers, lecturers and professors in bioinformatics, computational biology, medicine, pharmaceutics and other related fields. |
| drug discovery and development technology in transition: Atkinson's Principles of Clinical Pharmacology Shiew-Mei Huang, Juan J.L. Lertora, Paolo Vicini, Arthur J. Atkinson Jr., 2021-10-16 **Selected for Doody's Core Titles® 2024 in Pharmacology**Atkinson's Principles of Clinical Pharmacology, Fourth Edition is the essential reference on the pharmacologic principles underlying the individualization of patient therapy and contemporary drug development. This well-regarded survey continues to focus on the basics of clinical pharmacology for the development, evaluation and clinical use of pharmaceutical products while also addressing the most recent advances in the field. Written by leading experts in academia, industry, clinical and regulatory settings, the fourth edition has been thoroughly updated to provide readers with an ideal reference on the wide range of important topics impacting clinical pharmacology. - Presents the essential knowledge for effective practice of clinical pharmacology - Includes a new chapter and extended discussion on the role of personalized and precision medicine in clinical pharmacology - Offers an extensive regulatory section that addresses US and international issues and guidelines - Provides extended coverage of earlier chapters on transporters, pharmacogenetics and biomarkers, along with further discussion on Phase 0 studies (microdosing) and PBPK |
| drug discovery and development technology in transition: Practical Process Research & Development Neal G. Anderson, 2000-03 This book provides a comprehensive, step-by-step approach to organic process research and development in the pharmaceutical, fine chemical, and agricultural chemical industries. Process R&D describes the steps taken, following synthesis and evaluation, to bring key compounds to market in a cost-effective manner. More people are being hired for work in this area as increasing numbers of drug candidates are identified through combinatorial chemistry and high-throughput screening. The book is directed to industrial (primarily organic) chemists, and academicians (particularly those involved in a growing number of start-up companies) and students who need insight into industrial process R&D. Current books do not describe hands-on, step-by-step, approaches to solving process development problems, including route, reagent, and solvent selection; optimising catalytic reactions; chiral syntheses; and green chemistry. Practical Process Research and Development will be a valuable resource for researchers, managers, and graduate students. * Provides insights into generating rugged, practical, cost-effective processes for the chemical preparation of small molecules * Breaks down process optimization into route, reagent and solvent selection, development of reaction conditions, workup, crystallizations and more * Includes over 100 tips for rapid process development * Presents guidelines for implementing and troubleshooting processes |
Drug discovery and development: technology in transition
Essential insight into drug development and the pharmaceutical industry With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the …
Drug Discovery and Development: Technology in Transition
This book provides an introduction to the way the industry goes about the discovery and development of new drugs. The first part gives a brief historical account from its origins in the …
Drug Discovery and Development: Technology in Transition
Drug Discovery and Development: Technology in Transition. Paperback – 28 Aug. 2021. Essential insight into drug development and the pharmaceutical industry. With unprecedented interest in …
Drug Discovery and Development: Technology in Transition
24 Sep 2021 · Drug Discovery and Development: Technology in Transition. 3rd Edition. by Raymond G Hill (Editor), Duncan Richards (Editor) 4.2 16 ratings. See all formats and editions. …
Drug Discovery and Development - 3rd Edition - Elsevier Shop
Key stages of drug discovery and development ; Chapters outline the contribution of individual disciplines to the overall process; Supplemented by specific chapters on different modalities; …
Drug Discovery and Development - 2nd Edition - Elsevier Shop
Accessible, general guide to pharmaceutical research and development. Examines the interfaces between cost and social benefit, quality control and mass production, regulatory bodies, patent …
Drug Discovery and Development: Technology in Transition
Introduction. Clinically the unmet need for novel and safe drugs is becoming more significant due to increasing longevity in the developed world and the consequential increased prevalence of …
Drug Discovery and Development: Technology in Transition
13 Sep 2012 · Accessible, general guide to pharmaceutical research and development. Examines the interfaces between cost and social benefit, quality control and mass production, regulatory …
Drug Discovery and Development: Technology in Transition
In this section of the book we outline the main technical and experimental parts of the work that goes into drug development, namely toxicology, pharmaceutical development and clinical …
Drug Discovery and Development: Technology in Transition …
Essential insight into drug development and the pharmaceutical industry With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the …
Drug Discovery And Development Technology In Transition …
4 4 Drug Discovery And Development Technology In Transition 2023-12-29 revising the drug as necessary. Synthesis and Application Academic Press The drug discovery and
Drug Discovery And Development Technology In Transition
drug discovery and development technology in transition: Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays H. Gerhard Vogel, Franz J. Hock, Jochen Maas, Dieter Mayer, …
Drug Discovery And Development Technology In Transition 2e
Development Technology In Transition 2e Drug Discovery And Development Technology In Transition 2e M Tight When people should go to the books stores, search initiation by shop, …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 The Process of New Drug Discovery and Development G. Smith Charles,1992-08-24 The …
Drug Discovery And Development Technology In Transition …
Basic Principles of Drug Discovery and Development Drug Discovery and Development Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Drug Discovery …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development Raymond G Hill,Duncan Richards,2021-05-16 With …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery And Development Technology In Transition … Drug Discovery and Development, Third Edition presents up-to-date scientific information for maximizing the ability of a …
Drug Discovery And Development Technology In Transition 2E
Drug Discovery And Development Technology In Transition 2E Lauren Gardner Thank you for downloading Drug Discovery And Development Technology In Transition 2E. As you may …
Drug Discovery And Development Technology In Transition …
Drug Discovery And Development Technology In Transition: Feeling Good: The New Mood Therapy: David D. Burns This book focuses on the cognitive side of things, teaching you how …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development Raymond G Hill,Duncan Richards,2021-05-16 With …
Drug Discovery And Development Technology In Transition …
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development Raymond G. Hill,Duncan Richards,2021-06 Essential insight …
Drug Discovery And Development Technology In Transition 2e …
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01. ... Drug discovery and development continues to evolve rapidly and this new edition reflects …
Drug Discovery And Development Technology In Transition 2E
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Basic Principles of Drug Discovery and Development Benjamin E. Blass,2021-03-30 Basic …
Drug Discovery And Development Technology In Transition 2E
Technology In Transition 2e Drug Discovery And Development Technology In Transition 2E Enabling technologies such as high throughput screening, structure-based drug design, …
APPLICATIONS OF TRANSITION METAL CATALYSIS IN DRUG DISCOVERYAND DEVELOPMENT
Applications of transition metal catalysis in drug discovery and development : an industrial perspective / edited by Matthew L. Crawley, Barry M. Trost. p. ; cm. ... transition metal, most …
Drug Discovery And Development Technology In Transition 2E
Drug Discovery And Development Technology In Transition 2E Jaan A. Pesti,Ahmed F. Abdel-Magid,Rajappa Vaidyanathan Drug Discovery and Development Raymond G. Hill,Duncan …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 New Drug Development J. Rick Turner,2010-07-16 New Drug Development: Second Edition …
Drug Discovery And Development Technology In Transition 2E
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development, Third Edition James J. O'Donnell,John Somberg,Vincent …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development, Third Edition James J. O'Donnell,John Somberg,Vincent …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development - E-Book Raymond G Hill,2012-07-20 The modern …
Drug Discovery And Development Technology In Transition 2e …
You may not be perplexed to enjoy all books collections Drug Discovery And Development Technology In Transition 2e that we will unconditionally offer. It is not with reference to the …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 The Process of New Drug Discovery and Development G. Smith Charles,1992-08-24 The …
Drug Discovery And Development Technology In Transition 2e …
Drug Discovery And Development Technology In Transition 2e [PDF] Clare Sansom Social Aspects of Drug Discovery, Development and Commercialization Odilia Osakwe,Syed A.A. …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 New Drug Development J. Rick Turner,2010-07-16 New Drug Development: Second Edition …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development, Third Edition James J. O'Donnell,John Somberg,Vincent …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 The Process of New Drug Discovery and Development G. Smith Charles,1992-08-24 The …
Drug Discovery And Development Technology In Transition 2E
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 New Drug Development J. Rick Turner,2010-07-16 New Drug Development: Second Edition …
Drug Discovery And Development Technology In Transition 2e …
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development Raymond G. Hill,Duncan Richards,2021-06 Essential insight …
Drug Discovery And Development Technology In Transition 2E
17 Apr 2013 · Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development - E-Book Raymond G Hill,2012-07-20 The …
Drug Discovery And Development Technology In Transition 2E
16 Jul 2010 · Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development - E-Book Raymond G Hill,2012-07-20 The …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development - E-Book Raymond G Hill,2012-07-20 The modern …
Drug Discovery And Development Technology In Transition 2E
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development - E-Book Raymond G Hill,2012-07-20 The modern …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development, Third Edition James J. O'Donnell,John Somberg,Vincent …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 New Drug Development J. Rick Turner,2007-07-27 This book acquaints students and …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 New Drug Development J. Rick Turner,2010-07-16 New Drug Development: Second Edition …
Drug Discovery And Development Technology In Transition 2E
interested in … Drug Discovery And Development Technology In Transition 2e Drug Discovery And Development Technology In Transition 2e New Drug Development J. Rick Turner,2014-10 …
Drug Discovery And Development Technology In Transition 2E
9 Oct 2023 · Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 New Drug Development J. Rick Turner,2010-07-16 New Drug Development: …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery And Development Technology In Transition 2e Houng-Yau Mei,Anthony W. Czarnik Drug Discovery and Development - E-Book Raymond G Hill,2012-07-20 The modern …
Drug Discovery And Development Technology In Transition 2E
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 Drug Discovery and Development - E-Book Raymond G Hill,2012-07-20 The modern …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 The Process of New Drug Discovery and Development G. Smith Charles,1992-08-24 The …
Drug Discovery And Development Technology In Transition 2e
Drug Discovery & Development: Technology in Transition (Orig. Price: 38.99) Rang,2009-06-01 New Drug Development J. Rick Turner,2010-07-16 New Drug Development: Second Edition …
